Marek Jarema

UNVERIFIED PROFILE

Are you Marek Jarema?   Register this Author

Register author

Marek Jarema

Publications by authors named "Marek Jarema"

Are you Marek Jarema?   Register this Author

57Publications

-Reads

Hypersomnia and cognitive impairment in a patient with bipolar disorder - a case report.

Psychiatr Pol 2017 Jun 18;51(3):483-494. Epub 2017 Jun 18.

III Klinika Psychiatryczna, Instytut Psychiatrii i Neurologii w Warszawie.

View Article
June 2017

Effects of cognitive remediation therapy versus other interventions on cognitive functioning in schizophrenia inpatients.

Neuropsychol Rehabil 2017 May 1:1-12. Epub 2017 May 1.

c Department of Psychology , Institute of Psychiatry, King's College London , London , United Kingdom.

View Article
May 2017

Letter to Editor. In search of definition of the term "psychotic process" - thoughts and doubts.

Psychiatr Pol 2017 Apr 30;51(2):383-386. Epub 2017 Apr 30.

III Klinika Psychiatryczna, Instytut Psychiatrii i Neurologii w Warszawie.

View Article
April 2017

Paliperidone palmitate: effectiveness, safety, and the use for treatment of schizophrenia.

Psychiatr Pol 2017 Feb 26;51(1):7-21. Epub 2017 Feb 26.

Klinika Psychiatrii Dorosłych UM w Poznaniu.

View Article
February 2017

Clinical determinants of mental disorders occurring during the infertility treatment.

Psychiatr Pol 2015 ;49(5):965-82

III Klinika Psychiatryczna IPiN w Warszawie.

View Article
December 2016

Body Image and Body Experience Disturbances in Schizophrenia: an Attempt to Introduce the Concept of Body Self as a Conceptual Framework.

Curr Psychol 2018 25;37(1):390-400. Epub 2016 Nov 25.

2III Psychiatric Clinic, Institute of Psychiatry and Neurology, Sobieskiego 9 Street, 02-957 Warsaw, PL Poland.

View Article
November 2016

Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia part I: Neurophysiology.

World J Biol Psychiatry 2015 ;16(5):280-90

Department of Psychiatry, University Hospital Cochin (site Tarnier), University of Paris-Descartes, INSERM U 894 Centre Psychiatry and Neurosciences , Paris , France.

View Article
May 2016

Letter to the editors.

Int J Psychiatry Clin Pract 2007 ;11(1):81

Department of Adult Psychiatry, Pozhan University of Medical Sciences, Pozhan, Poland.

View Article
October 2015

[Guidelines for the use of second-generation long-acting antipsychotics].

Psychiatr Pol 2015 Mar-Apr;49(2):225-41

Klinika Psychiatrii Dorosłych Uniwersytetu Medycznego im. K. Marcinkowskiego w Poznaniu.

View Article
August 2015

Functional polymorphism of matrix metalloproteinase-9 (MMP9) gene is not associated with schizophrenia and with its deficit subtype.

Pharmacol Rep 2015 Jun 27;67(3):442-5. Epub 2014 Nov 27.

Department of Clinical Psychology, Institute of Psychology, University of Szczecin, Szczecin, Poland. Electronic address:

View Article
June 2015

Electroencephalographic theta activity and cognition in schizophrenia: preliminary results.

World J Biol Psychiatry 2015 Apr 24;16(3):206-10. Epub 2014 Oct 24.

Third Department of Psychiatry, Institute of Psychiatry and Neurology , Warsaw , Poland.

View Article
April 2015

[Cognitive dysfunctions in depression - underestimated symptom or new dimension?].

Psychiatr Pol 2014 Nov-Dec;48(6):1105-16

Klinika Psychiatrii UM w Lublinie.

View Article
April 2015

[Cognitive rehabilitation for people living with schizophrenia - the newest interventions].

Psychiatr Pol 2014 Nov-Dec;48(6):1179-88

III Klinika Psychiatryczna IPiN w Warszawie.

View Article
April 2015

Age or age at onset? Which of them really matters for neuro and social cognition in schizophrenia?

Psychiatry Res 2015 Jan 24;225(1-2):197-201. Epub 2014 Nov 24.

Third Department of Psychiatry, Institute of Psychiatry and Neurology, Sobieskiego 9, 02-957 Warsaw, Poland.

View Article
January 2015

Daytime sleepiness and EEG abnormalities in patients treated with second generation antipsychotic agents.

Pharmacol Rep 2014 Dec 2;66(6):1077-82. Epub 2014 Aug 2.

Third Department of Psychiatry, Institute of Psychiatry and Neurology, Warszawa, Poland. Electronic address:

View Article
December 2014

[Between health and schizophrenia].

Psychiatr Pol 2013 Jul-Aug;47(4):587-97

View Article
September 2014

Long-term assessment of the efficacy and tolerability of risperidone in early schizophrenia: An international multicenter study.

Int J Psychiatry Clin Pract 2004 ;8(3):147-52

Department of Adult Psychiatry, Poznan University of Medical Sciences, Poznan, Poland.

View Article
June 2014

Agomelatine in generalized anxiety disorder: an active comparator and placebo-controlled study.

J Clin Psychiatry 2014 Apr;75(4):362-8

University of Cape Town Department of Psychiatry, Groote Schuur Hospital, J-Block, Anzio Rd, Observatory, Cape Town 7925, South Africa

View Article
April 2014

Treatment of depression in first episode of schizophrenia: results from EUFEST.

Eur Neuropsychopharmacol 2012 Dec 23;22(12):875-82. Epub 2012 May 23.

Department of Adult Psychiatry, Poznan University of Medical Sciences, Poznan, Poland.

View Article
December 2012

Cytokines, sleep and wakefulness regulation, and general health: a commentary to the review "The influence of cytokines on wakefulness regulation".

Psychiatr Danub 2012 Jun;24(2):127-9

Third Department of Psychiatry, Institute of Psychiatry and Neurology, Warsaw, Poland.

View Article
June 2012

Actigraphic monitoring of activity and rest in schizophrenic patients treated with olanzapine or risperidone.

J Psychiatr Res 2011 Oct 15;45(10):1381-6. Epub 2011 Jun 15.

Third Department of Psychiatry, Institute of Psychiatry and Neurology, Sobieskiego, Warsaw, Poland.

View Article
October 2011

[Practical aspects of the use of ziprasidone in schizophrenia].

Psychiatr Pol 2010 Nov-Dec;44(6):881-93

III Klinika Psychiatryczna IPiN w Warszawie.

View Article
May 2011

[Antipsychotics in clinical practice. Treatment of the first schizophrenic episode].

Psychiatr Pol 2008 Nov-Dec;42(6):841-58

III Klinika Psychiatryczna IPiN w Warszawie.

View Article
June 2009

Herbal drug treatment.

Authors:
Marek Jarema

Neuro Endocrinol Lett 2008 Nov;29 Suppl 1:93-104

3rd Department of Psychiatry, Institute of Psychiatry and Neurology, Warszawa, Poland.

View Article
November 2008

Biological treatment of mental disorders.

Authors:
Marek Jarema

Neuro Endocrinol Lett 2008 Nov;29 Suppl 1:1-4

View Article
November 2008

A few facts from the history of selected biological treatment methods in psychiatry.

Authors:
Marek Jarema

Neuro Endocrinol Lett 2008 Nov;29 Suppl 1:5-9

3rd Department of Psychiatry, Institute of Psychiatry and Neurology, Warszawa, Poland.

View Article
November 2008

[Pharmacological standards in schizophrenia treatment].

Psychiatr Pol 2006 Nov-Dec;40(6):1171-205

Grupa Robocza powołana przez Konsultanta Krajowego w dziedzinie psychiatrii dia opracowania Standardów Leczenia w Psychiatrii.

View Article
May 2007

Strategies of long-term treatment of psychotic disorders.

Authors:
Marek Jarema

Neuro Endocrinol Lett 2007 Feb;28 Suppl 1:13-26

III Department of Psychiatry, Institute of Psychiatry and Neurology, Ul. Sobieskiego 9, 02-9578 Warszawa, Poland.

View Article
February 2007

Atypical antipsychotics in the treatment of mood disorders.

Authors:
Marek Jarema

Curr Opin Psychiatry 2007 Jan;20(1):23-9

III Department of Psychiatry, Institute of Psychiatry and Neurology, Warsaw, Poland.

View Article
January 2007

[Subjective and objective evaluation of olanzapine treatment in schizophrenia].

Psychiatr Pol 2004 Sep-Oct;38(5):895-909

III Kliniki Psychiatrycznej IPiN w Warszawie.

View Article
January 2005

[Second generation antipsychotics: similarities and differences].

Psychiatr Pol 2003 Jan-Feb;37(1):7-28

III Kliniki Psychiatrycznej IPiN w Warszawie.

View Article
July 2003

[Second generation of neuroleptics--expectations and the reality].

Authors:
Marek Jarema

Psychiatr Pol 2002 Nov-Dec;36(6 Suppl):209-16

III Klinika Psychiatryczna Instytutu Psychiatrii i Neurologii w Warszawie.

View Article
June 2003

[Current concepts of pharmacological treatment in schizophrenia].

Authors:
Marek Jarema

Psychiatr Pol 2002 Nov-Dec;36(6):857-68

III Kliniki Psychiatrycznej IPiN w Warszawie.

View Article
June 2003

[The change of quality of life and clinical picture in schizophrenia].

Psychiatr Pol 2002 May-Jun;36(3):393-402

III Kliniki Psychiatrycznej IPiN w Warszawie.

View Article
September 2002